About
Reticular develops polygenic prediction technology for embryo selection to help IVF couples plan their families and is building a platform aimed at addressing complex heritable diseases. The company applies ML/bio research and genomic models to improve prediction of genetic risk in reproductive contexts.
Explore Reticular's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.